The Medicines Company (MDCO) Could See Ph3 ORION Readout in First Week of September
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $48.00 price target on The Medicines Company (NASDAQ: MDCO) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
